Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Readers

    Page :A6

    

• Editorial

  • ·There and back again: The story of perioperative ?-blockade

    Page :617-618

    Daniel Alyeshmerni, Kim Eagle

    

• Trial Designs

  • ·Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: A comparison of fractional flow reserve–guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease

    Page :619

    Frederik M. Zimmermann, Bernard De Bruyne, Nico H.J. Pijls, Manisha Desai, Keith G. Oldroyd, Seung-Jung Park, Michael J. Reardon, Olaf Wendler, Joseph Woo, Alan C. Yeung, William F. Fearon

    Résumé Résumé Plan Plan  
  • ·Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF)

    Page :627

    Hisham Dokainish, Koon Teo, Jun Zhu, Ambuj Roy, Khalid Al-Habib, Ahmed ElSayed, Lia Palileo, Patricio Lopez Jaramillo, Kamilu Karaye, Khalid Yusoff, Andres Orlandini, Karen Sliwa, Charles Mondo, Fernando Lanas, Prabhakar Dorairaj, Mark Huffman, Amr Badr, Mohamed Elmaghawry, Albertino Damasceno, Emilie Belley-Cote, Karen Harkness, Alex Grinvalds, Robert McKelvie, Salim Yusuf

    Résumé Résumé Plan Plan  
  • ·A randomized controlled trial of the efficacy and safety of varenicline for smoking cessation after acute coronary syndrome: Design and methods of the Evaluation of Varenicline in Smoking Cessation for Patients Post-Acute Coronary Syndrome trial

    Page :635

    Sarah B. Windle, Iqbal Bata, Mina Madan, Beth L. Abramson, Mark J. Eisenberg

    Résumé Résumé Plan Plan  
  • ·Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: Design of and rationale for the ABSORB III randomized trial

    Page :641

    Dean J. Kereiakes, Stephen G. Ellis, Jeffrey J. Popma, Peter J. Fitzgerald, Habib Samady, Jennifer Jones-McMeans, Zhen Zhang, Wai-Fung Cheong, Xiaolu Su, Ori Ben-Yehuda, Gregg W. Stone

    Résumé Résumé Plan Plan  
  • ·Granulocyte-colony stimulating factor for large anterior ST-elevation myocardial infarction: Rationale and design of the prospective randomized phase III STEM-AMI OUTCOME trial

    Page :652

    Felice Achilli, Cristina Malafronte, Francesca Cesana, Stefano Maggiolini, Ciro Mauro, Gaetano M. De Ferrari, Laura Lenatti, Maurizio Tespili, Paola Pasqualini, Francesco Gentile, Maurizio C. Capogrossi, Aldo Maggioni, Attilio Maseri, Gianluca Pontone, Gualtiero I. Colombo, Giulio Pompilio, STEM-AMI OUTCOME Trial Investigators

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Implications of new-onset atrial fibrillation after cardiac surgery on long-term prognosis: A community-based study

    Page :659-668

    Rowlens M. Melduni, Hartzell V. Schaff, Kent R. Bailey, Stephen S. Cha, Naser M. Ammash, James B. Seward, Bernard J. Gersh

    Résumé Résumé Plan Plan  
  • ·Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: Results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial

    Page :669-674

    Bram J. Geller, Robert P. Giugliano, Eugene Braunwald, Sabina A. Murphy, James J. Hanyok, Jianqing Jin, Michele Mercuri, Elliott M. Antman, Christian T. Ruff

    Résumé Résumé Plan Plan  
  • ·Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)

    Page :675

    Sameer Bansilal, Zachary Bloomgarden, Jonathan L. Halperin, Anne S. Hellkamp, Yuliya Lokhnygina, Manesh R. Patel, Richard C. Becker, Günter Breithardt, Werner Hacke, Graeme J. Hankey, Christopher C. Nessel, Daniel E. Singer, Scott D. Berkowitz, Jonathan P. Piccini, Kenneth W. Mahaffey, Keith A.A. Fox, ROCKET AF Steering Committee and Investigators

    Résumé Résumé Plan Plan  
  • ·Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial

    Page :683

    Jose Carlos Nicolau, Deepak L. Bhatt, Matthew T. Roe, Yuliya Lokhnygina, Benjamin Neely, Ramón Corbalán, José L. Leiva-Pons, Felipe Martinez, Shaun G. Goodman, Kenneth J. Winters, Freek W.A. Verheugt, Paul W. Armstrong, Harvey D. White, Keith A.A. Fox, Dorairaj Prabhakaran, E. Magnus Ohman, TRILOGY ACS investigators

    Résumé Résumé Plan Plan  
  • ·Long-term outcomes for women versus men with unstable angina/non–ST-segment elevation myocardial infarction managed medically without revascularization: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial

    Page :695

    Peter Clemmensen, Matthew T. Roe, Judith S. Hochman, Derek D. Cyr, Megan L. Neely, Darren K. McGuire, Jan H. Cornel, Kurt Huber, Dmitry Zamoryakhin, Harvey D. White, Paul W. Armstrong, Keith A.A. Fox, Dorairaj Prabhakaran, Erik Magnus Ohman, TRILOGY ACS Investigators

    Résumé Résumé Plan Plan  
  • ·Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States

    Page :706-714

    Tracy Y. Wang, Timothy D. Henry, Lisa A. McCoy, Peter B. Berger, David J. Cohen, Mark B. Effron, Marjorie Zettler, Brian A. Baker, John C. Messenger, Eric D. Peterson

    Résumé Résumé Plan Plan  
  • ·High-sensitivity troponin T predicts infarct scar characteristics and adverse left ventricular function by cardiac magnetic resonance imaging early after reperfused acute myocardial infarction

    Page :715

    Tuan L. Nguyen, Justin A.K. Phan, Leia Hee, Daniel A. Moses, James Otton, Owen D. Terreblanche, Jessica Xiong, Upul Premawardhana, Rohan Rajaratnam, Craig P. Juergens, Hany R. Dimitri, John K. French, David A.B. Richards, Liza Thomas

    Résumé Résumé Plan Plan  
  • ·Blood transfusion, bleeding, anemia, and survival in patients with acute myocardial infarction: FAST-MI registry

    Page :726

    Gregory Ducrocq, Etienne Puymirat, Philippe Gabriel Steg, Patrick Henry, Michel Martelet, Carma Karam, François Schiele, Tabassome Simon, Nicolas Danchin

    Résumé Résumé Plan Plan  
  • ·The association of chronic kidney disease with the use of renin-angiotensin system inhibitors after acute myocardial infarction

    Page :735-743

    James B. Wetmore, Fengming Tang, Abhinav Sharma, Philip G. Jones, John A. Spertus

    Résumé Résumé Plan Plan  
  • ·The relation between the presence of cardiovascular disease and vascular risk factors in offspring and the occurrence of new vascular events in their parents already at high vascular risk

    Page :744

    Maaike Weijmans, Yolanda van der Graaf, Gert Jan de Borst, Folkert W. Asselbergs, Maarten J. Cramer, Ale Algra, Frank L.J. Visseren, SMART study group h

    Résumé Résumé Plan Plan  
  • ·Glucose-Lowering Medications and Angina Burden in Patients with Stable Coronary Disease: Results from the Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina (TERISA) Trial

    Page :753

    Suzanne V. Arnold, Darren K. McGuire, John A. Spertus, Fengming Tang, Patrick Yue, Silvio E. Inzucchi, Luiz Belardinelli, Bernard R. Chaitman, Mikhail Kosiborod

    Résumé Résumé Plan Plan  
  • ·Undiagnosed diabetes is prevalent in younger adults and associated with a higher risk cardiometabolic profile compared to diagnosed diabetes

    Page :760

    Yong-ho Lee, Ehrin J. Armstrong, Gyuri Kim, Jaewon Oh, Seok-Min Kang, Byung-Wan Lee, Chul Woo Ahn, Bong Soo Cha, Hyun Chul Lee, Christos S. Mantzoros, Eun Seok Kang

    Résumé Résumé Plan Plan  
  • ·Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: The Look AHEAD randomized trial

    Page :770

    Alvaro Alonso, Judy L. Bahnson, Sarah A. Gaussoin, Alain G. Bertoni, Karen C. Johnson., Cora E. Lewis, Marion Vetter, Christos S. Mantzoros, Robert W. Jeffery, Elsayed Z. Soliman, Look AHEAD Research Group

    Résumé Résumé Plan Plan  
  • ·Incidence and consequence of major bleeding in primary percutaneous intervention for ST-elevation myocardial infarction in the era of radial access: an analysis of the international randomized Acute myocardial infarction Treated with primary angioplasty and intravenous enoxaparin Or unfractionated heparin to Lower ischemic and bleeding events at short- and Long-term follow-up trial

    Page :778-786

    Cyril Pellaton, Guillaume Cayla, Johanne Silvain, Uwe Zeymer, Marc Cohen, Patrick Goldstein, Kurt Huber, Charles Pollack, Mathieu Kerneis, Jean-Philippe Collet, Eric Vicaut, Gilles Montalescot, ATOLL Investigators

    Résumé Résumé Plan Plan  
  • ·Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: Results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial

    Page :787

    David J. Kurz, Alain M. Bernheim, David Tüller, Rainer Zbinden, Raban Jeger, Christoph Kaiser, Soeren Galatius, Kim W. Hansen, Hannes Alber, Matthias Pfisterer, Franz R. Eberli

    Résumé Résumé Plan Plan  
  • ·Relationship between stent type and quality of life after percutaneous coronary intervention for acute myocardial infarction

    Page :796

    Adnan K. Chhatriwalla, Lakshmi Venkitachalam, Kevin F. Kennedy, Joshua M. Stolker, Philip G. Jones, David J. Cohen, John A. Spertus

    Résumé Résumé Plan Plan  
  • ·Variation in use of echocardiography among veterans who use the Veterans Health Administration vs Medicare

    Page :805-811

    Vinay Kini, Fenton H. McCarthy, Sheeva Rajaei, Andrew J. Epstein, Paul A. Heidenreich, Peter W. Groeneveld

    Résumé Résumé Plan Plan  
  • ·Patterns of ?-blocker initiation in patients undergoing intermediate to high-risk noncardiac surgery

    Page :812

    Elisabetta Patorno, Shirley V. Wang, Sebastian Schneeweiss, Jun Liu, Brian T. Bateman

    Résumé Résumé Plan Plan  
  • ·Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement

    Page :821-829

    Jan-Malte Sinning, Kai C. Wollert, Alexander Sedaghat, Christian Widera, Marie-Caroline Radermacher, Claire Descoups, Christoph Hammerstingl, Marcel Weber, Anja Stundl, Alexander Ghanem, Julian Widder, Mariuca Vasa-Nicotera, Fritz Mellert, Wolfgang Schiller, Johann Bauersachs, Berndt Zur, Stefan Holdenrieder, Armin Welz, Eberhard Grube, Michael J. Pencina, Georg Nickenig, Nikos Werner, Tibor Kempf

    Résumé Résumé Plan Plan  
  • ·Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN

    Page :830-836

    Daniel C. DeSimone, Imad M. Tleyjeh, Daniel D. Correa de Sa, Nandan S. Anavekar, Brian D. Lahr, Muhammad R. Sohail, James M. Steckelberg, Walter R. Wilson, Larry M. Baddour

    Résumé Résumé Plan Plan  
  • ·Impact of lung diseases on morbidity and mortality after transcatheter aortic valve implantation: Insights from spirometry and body plethysmography

    Page :837

    Michael Gotzmann, Heiko Knoop, Aydan Ewers, Andreas Mügge, Jörg W. Walther

    Résumé Résumé Plan Plan